Pharmaceutical policy -- Latin America : Balancing wealth and health : the battle over intellectual property and access to medicines in Latin America / edited by Rochelle Dreyfuss, César Rodríguez-Garavito
Pharmaceutical policy -- United States -- Congresses : The safe use initiative and health literacy : workshop summary / Cori Vancheri, rapporteur ; Roundtable on Health Literacy, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies
2010?
1
Pharmaceutical policy -- United States -- Decision making -- Congresses : Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products : workshop summary / Denise Caruso, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Pharmaceutical policy -- United States -- Regulations -- Congresses : Strengthening a workforce for innovative regulatory science in therapeutics development : workshop summary / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals
